MSB 3.33% $1.40 mesoblast limited

like others, Collie puzzles me. Firstly it was maintain the...

  1. 203 Posts.
    like others, Collie puzzles me. Firstly it was maintain the $5.40 target, then a further downgrade!! And the ph 3 is going ahead. Plus shortly anns re spinal applications, lumbar plus diabetes? Or are we a one trick pony?
    I'd advise that all holders keep writing to ASIC and the ASX to clarify the short selling and associated trading.
    I think that the identities of shorters should be information freely available to all the market. And not just the nominee companies. This carp has gone on for too long. How is it that short position reduces by half with nothing like those numbers traded? It's garbage and it's undermining the integrity of the market.
    Meanwhile, MSB will hopefully derisk by aligning with another BP rather than relying on Teva. We ARE more than a one trick pony, which MSB in the next 2 months will illustrate graphically
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.